The two-day event, titled “Update on Cancer Treatment and Nuclear Medicine,” was organized by the Bach Mai Hospital’s Center for Nuclear Medicine and Oncology, with the participation of around 1,000 domestic and international medical experts.
According to World Health Organization (WHO) statistics, nearly 20 million new cases of cancer are recorded globally each year, with about 10 million deaths. In Vietnam, more than 180,000 new cases and over 122,000 deaths are reported annually.
    |
 |
|
Director of Bach Mai Hospital Dao Xuan Co speaks at the symposium on August 16. |
The incidence and mortality of cancer in Vietnam continue to rise, particularly for lung, liver, breast, stomach, and colorectal cancers. These types are not only the most common but also among the deadliest if not detected and treated early. Lung cancer, in particular, is considered a “silent killer,” accounting for the highest incidence in men in many countries, including Vietnam.
Speaking at the event, Bach Mai Hospital Director Prof. Dao Xuan Co stressed that cancer remains the leading health burden both globally and in Vietnam, requiring the health system to constantly improve its capacity in diagnosis, treatment, and patient care.
“This is an alarming figure, reflecting the need for a comprehensive and synchronized strategy in early diagnosis, targeted treatment, and holistic care for cancer patients,” Prof. Co said.
He also emphasized that the application of advanced diagnostic and treatment techniques is essential to improve treatment outcomes and extend patients’ lives.
According to Prof., Dr. Mai Trong Khoa, former Deputy Director of Bach Mai Hospital, the rising burden of cancer is not only linked to population growth and longevity but also to modern lifestyles and increasingly polluted living environments. Factors such as dust, chemicals, pesticides, gasoline fumes, alcohol, and especially cigarettes, both traditional and electronic, are severely impacting public health.
“It is worrying that the age of smoking initiation is becoming younger, even spreading into schools. Passive smoking is also a constant danger when living and working environments are not strictly controlled. Hundreds of toxic substances in cigarette smoke create favorable conditions for cancer development, particularly lung cancer,” Prof. Khoa said.
Assoc. Prof., Dr. Pham Cam Phuong, Director of the Center for Nuclear Medicine and Oncology, emphasized that nuclear medicine plays a vital role in early cancer diagnosis and in monitoring treatment response through functional imaging techniques such as PET/CT, SPECT/CT, and SPECT. These methods enable the assessment of cancer cell metabolism even before morphological lesions appear, allowing early and accurate detection of metastasis.
“Therefore, nuclear medicine supports individualized treatment, tailoring regimens to each patient based on the biological characteristics of their tumor. It can be said that this is a pioneering field in precision medicine, contributing significantly to improved treatment outcomes and quality of life for cancer patients,” Prof. Phuong said.
Experts also noted that in treatment, targeted radiation therapies such as I-131, Lu-177, and theragnostics make it possible to precisely localize lesions and assess treatment response in real time. These approaches help destroy cancer cells while minimizing damage to healthy tissue.
Prof. Dao Xuan Co added: “The advancement of modern diagnostic methods such as next-generation sequencing (NGS) and genetic-level disease diagnosis, combined with targeted drugs and immunotherapy, has prolonged survival and enhanced the quality of life for patients.”
At the symposium, experts held three consecutive training sessions on immunotherapy in lung cancer, gastrointestinal cancer, and nuclear medicine applications in diagnosis and treatment. Participants also discussed new advances in treating specific cancers such as breast, gastrointestinal and lung cancers, alongside innovations in radiotherapy and nuclear medicine.
The biennial symposium serves as a platform for doctors to exchange expertise, explore new approaches in cancer treatment, and contribute to improving patient care and quality of life.
Source: VNA